Xconomy: Memorial Sloan-Kettering Cancer Center News, Articles and Opinions

“memorial-sloan-kettering-cancer-center” Archives

Entry	Author	Date	Location
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work	Ben Fidler	08/08/19	Boston
Redox Wrangles $33M to Become Healthcare’s Go-To Data Integrator	Jeff Bauter Engel	04/18/19	Wisconsin
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results	Ben Fidler	04/03/19	National
Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More	Frank Vinluan	01/07/19	National
Tiburio Launches from Cydan with $31M to Tackle Pituitary Tumors	Frank Vinluan	01/03/19	Boston
NY’s Research Institutions Must Keep Working Together in ‘19	Orin Herskowitz	12/31/18	New York
ImageMoverMD Nabs Another $1.6M For Secure Patient Photo-Sharing App	Jeff Buchanan	09/28/18	Wisconsin
Y-mAbs Upsizes IPO, Gets $96M to Test Two Pediatric Cancer Drugs	Frank Vinluan	09/21/18	New York
Y-mAbs Plans IPO to Advance Two Pediatric Cancer Drugs to the FDA	Frank Vinluan	08/27/18	New York
Gregor Diagnostics Raises $900K to Develop New Prostate Cancer Test	Jeff Buchanan	07/10/18	Wisconsin
Drugs OK’d To Hit Tumor Genes Still a Basket of One. Are More Coming?	Alex Lash	05/31/18	National
CMS Starts to Cover Broad Cancer DNA Tests, Boosting Foundation, Thermo	Ben Fidler	03/19/18	Boston
Roche Bets $1.7B More on Precision Oncology With Ignyta Deal	Ben Fidler	12/22/17	San Diego
Will Foundation’s FDA, CMS Nod Help Cancer DNA Tests Break Through?	Ben Fidler	12/01/17	Boston
UT Nominates MD Anderson Alum Peter Pisters to Replace DePinho	Angela Shah	08/25/17	Texas
Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests?	Ben Fidler	06/03/17	National
Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech	Ben Fidler	12/30/16	New York
Flatiron, Foundation Med Link Records of 20,000 Cancer Patients	Alex Lash	11/03/16	New York
All In One Place: A New Immuno-Oncology Trial Resource	Alex Lash	10/19/16	National
Bio Roundup: Cancer Wishes and Shopping Lists, Allergan Pricing & More	Alex Lash	09/09/16	National
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches	Alex Lash	09/07/16	National
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial	David Holley	07/07/16	Seattle
Rgenix Raises $33M, Preps Cancer Trial For Drug Shelved By GSK	Alex Lash	06/15/16	New York
East Coast Biotech Roundup: Intellia, What’s Hot, Cydan, Fog & More	Ben Fidler	04/14/16	Boston
New York City: En Route to a Bio Cluster	Louis Levy and Vicki Sato	02/29/16	New York
Rockefeller’s Tessier-Lavigne Heads Back to the Bay to Run Stanford	Ben Fidler	02/04/16	New York
Blood Simple? Grail’s Cancer Screening Quest Faces Tough Questions	Alex Lash	02/04/16	National
Led By Biotech Stars, ORIC Nabs $53M To Fight Drug-Resistant Cancer	Alex Lash	12/02/15	San Francisco
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology	Ben Fidler	10/20/15	San Francisco
Amid Nobel Prize Suspense, Making Sense Of Latest Gene-Editing News	Alex Lash	10/06/15	National
Page 1 of 4	next page »

Underwriters and Partners

Xpertise: Watch + Learn

Xconomy Insight · Webinar
The New Era of Emerging Therapies Webinar Series
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Sponsored · Whitepaper
Monitoring Solutions for Pharma-CRO/CMO Partnerships to Maintain Quality & Timelines
Implementing electronic solutions for risk mitigation
XiltriX